+34 656 7900
L - J: 08:30 - 17:30 | V: 8:30 - 14:30
Cell Therapy and Biologic Medicinal Products
Japanese company REPROCELL invests in Histocell
Histocell inaugurates new manufacturing plant for advanced therapy medicinal products
Cardiva expands its business by acquiring a stake in the biopharmaceutical company Histocell
Histocell and Cardiva join forces to introduce the innovative wound care product Reoxcare throughout the Spanish healthcare system.
Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by covid-19